METYROSINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metyrosine, and what generic alternatives are available?
Metyrosine is a drug marketed by Amneal and is included in one NDA.
The generic ingredient in METYROSINE is metyrosine. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the metyrosine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metyrosine
A generic version of METYROSINE was approved as metyrosine by AMNEAL on July 24th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METYROSINE?
- What are the global sales for METYROSINE?
- What is Average Wholesale Price for METYROSINE?
Summary for METYROSINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Clinical Trials: | 4 |
Patent Applications: | 3,492 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for METYROSINE |
What excipients (inactive ingredients) are in METYROSINE? | METYROSINE excipients list |
DailyMed Link: | METYROSINE at DailyMed |
Recent Clinical Trials for METYROSINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sarcoma Oncology Research Center, LLC | Phase 2 |
Tyme, Inc | Phase 2 |
Joseph Ahmed Foundation | Phase 2 |
Pharmacology for METYROSINE
Drug Class | Catecholamine Synthesis Inhibitor |
Mechanism of Action | Catecholamine Synthesis Inhibitors |
US Patents and Regulatory Information for METYROSINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal | METYROSINE | metyrosine | CAPSULE;ORAL | 213734-001 | Jul 24, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |